Cargando…

The EGF receptor family as targets for breast cancer therapy

Detalles Bibliográficos
Autor principal:	Baselga, J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2000
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3300881/ http://dx.doi.org/10.1186/bcr183

Ejemplares similares

Targeting the cell cycle for prognosis and therapy of breast cancer
por: Keyomarsi, K, et al.
Publicado: (2005)

Targeting new therapies in combination with hormonal therapies for ER-positive breast cancer
por: Dowsett, M
Publicado: (2005)

Tumour-selective transcriptional targeting for breast cancer gene therapy
por: Hurst, HC
Publicado: (2000)

Differentiation therapy: targeting breast cancer stem cells to reduce resistance to radiotherapy and chemotherapy
por: Roy, R, et al.
Publicado: (2010)

Genomic analysis of human breast cancer in families and populations
por: King, M-C
Publicado: (2005)

Targeting the EGF Receptor for Ovarian Cancer Therapy
por: Zeineldin, Reema, et al.
Publicado: (2010)

Adjuvant therapy of HER2(+ )breast cancer
por: Winer, EP
Publicado: (2009)

Regulation of recombinational repair by the familial breast cancer susceptibility protein BRCA2
por: West, SC, et al.
Publicado: (2006)

Telomerase: a breast cancer chemopreventive and therapeutic target
por: Shay, JW
Publicado: (2000)

Targeting HER2 in breast cancer: beyond trastuzumab
por: Winer, EP
Publicado: (2011)

Design of RESILIENCE: a phase 3 trial comparing capecitabine in combination with sorafenib or placebo for treatment of locally advanced or metastatic HER2-negative breast cancer
por: Baselga, J, et al.
Publicado: (2011)

DNA methylome of familial breast cancer identifies distinct profiles defined by mutation status
por: Flanagan, JM, et al.
Publicado: (2010)

Predicting response/resistance to endocrine therapy for breast cancer
por: Miller, WR, et al.
Publicado: (2005)

Adjuvant therapy after preoperative treatment for breast cancer
por: Ciruelos, E
Publicado: (2009)

SOLTI (Solid Tumor Intensification) Group experience with high-dose chemotherapy treatment for early breast carcinoma
por: Funes, H Cortés, et al.
Publicado: (2005)

Toll-like receptor family: receptors essential for microbial recognition and immune responses
por: Akira, S, et al.
Publicado: (2003)

Combined hormonal therapy for advanced breast cancer in postmenopausal patients
por: Langecker, P, et al.
Publicado: (2003)

Targeting estrogen to kill ER-positive and ER-negative breast cancer
por: Jordan, VC
Publicado: (2005)

Vaccine targeting HIF1A in triple negative breast cancer
por: Cecil, Denise, et al.
Publicado: (2014)

Canakinumab therapy in patients with Familial Mediterranean Fever
por: Ugurlu, S, et al.
Publicado: (2015)

Fcγ receptor targeting in RA
por: Takai, Toshiyuki, et al.
Publicado: (2012)

Transforming growth factor-beta co-receptor endoglin suppresses breast cancer invasion and metastasis
por: Henry, LA, et al.
Publicado: (2010)

Translational breast cancer research in luminal breast cancer
por: Dowsett, M
Publicado: (2011)

Insulin-like growth factor binding protein 3 modulates epidermal growth factor (EGF)-induced growth of breast epithelial cells by altering EGF receptor internalization
por: Dennison, GJ, et al.
Publicado: (2008)

Long-term survival of interval breast cancers in breast cancer screening in Wales
por: Fong, YF, et al.
Publicado: (2012)

Using Family Based Therapy (FBT) for older adolescents: strengths and difficulties
por: McLeod, Lisa, et al.
Publicado: (2013)

Use of mouse models to validate and therapeutically target transforming growth factor beta as an important player in breast cancer progression
por: Wakefield, LM, et al.
Publicado: (2003)

Rational immunogen design to target specific germline B cell receptors
por: Jardine, J, et al.
Publicado: (2012)

Predictive factors in breast cancer
por: Klijn, J, et al.
Publicado: (2000)

Neratinib, an irreversible pan erB receptor tyrosine kinase inhibitor active for advanced HER2(+ )breast cancer
por: Cortés-Funes, H, et al.
Publicado: (2009)

Targeting secreted heat shock protein-90alpha (Hsp90α) to prevent breast cancer progression
por: Zhao, Zhengwei, et al.
Publicado: (2010)

Abdominal and pelvic complications of molecular targeted therapy
por: Gore, Richard M, et al.
Publicado: (2014)

Is ultrasound axillary staging less accurate in invasive lobular breast cancer than in ductal breast cancer?
por: Sankaye, P, et al.
Publicado: (2012)

Epigenetics of breast cancer
por: Esteller, M
Publicado: (2011)

Stem cells in normal breast development and breast cancer
por: Wicha, MS, et al.
Publicado: (2003)

Multiple family therapy for anorexia nervosa at the Eating Disorder Service, the Children's Hospital at Westmead
por: Wallis, Andrew, et al.
Publicado: (2015)

Molecular mechanisms of resistance to HER2-targeted therapy
por: Esteva, FJ
Publicado: (2009)

Minimising oncological treatment of early breast cancer
por: Yarnold, J
Publicado: (2008)

Candidate targets for antibody therapy of rheumatoid arthritis: CD64 and IL-15
por: van de Winkel, J
Publicado: (2003)

Update on breast cancer genetics
por: Izatt, L
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_s47ciano1p0t5h2srvnm0ikfto